Source notes

Preparing for a severe allergic reaction involves more than avoiding a known trigger. Anaphylaxis can progress rapidly, and recognition, access to epinephrine and a clear response plan all matter. This update examines seven areas of diagnosis and management, combining published evidence with clinical expertise. It addresses children, community settings, underlying disorders and reactions around surgery, among other topics. One pooled analysis discussed in the document found that 7.7% of anaphylaxis cases across ages and causes received more than one epinephrine dose. Planning therefore needs to account for an incomplete response or returning symptoms.

The recommendations have different levels of certainty. Some are strong despite limited trial evidence because the expected benefit outweighs the harm. Others depend more heavily on the patient's circumstances and preferences. Diagnosis is also a clinical judgment: giving epinephrine does not by itself prove that a reaction was anaphylaxis. Conversely, the authors say that formal diagnostic criteria need not be fully met before treating suspected anaphylaxis.

How Does This Show Up in Real Life?

For someone prescribed an epinephrine autoinjector, having the device is only part of preparation. The authors recommend repeated discussion of when to use it, how to operate it and how to keep it available, with practice using a trainer. They suggest giving epinephrine at the first sign of suspected anaphylaxis. The response plan should also cover what happens next. Severe symptoms, symptoms that fail to resolve promptly and fully or nearly fully, and symptoms that return or worsen require emergency services. Decisions about observation after a complete response require clinician counselling and ready access to further medication and medical care. For meals away from home, the paper emphasises communicating the allergy clearly to food-service staff and preventing accidental ingestion of the trigger.

Many recommendations rely on observational studies or expert consensus, with low or very low certainty. Definitions of anaphylaxis differ between studies, and reliable tools for predicting future reaction severity are lacking. The best frequency of device training remains uncertain; a single teaching session may not produce lasting improvement. This update covers selected topics and complements earlier guidance rather than replacing every previous recommendation.

The document is most useful as a basis for an individual plan made with a clinician. Its detail helps explain why preparation and follow-up involve more than a prescription, while its evidence ratings show which decisions remain sensitive to uncertainty and personal circumstances.